Kreye, J., Reincke, S. M., Edelburg, S., Jeworowski, L. M., Kornau, H., Trimpert, J., . . . Prüss, H. (2023). Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron. Elsevier.
Chicago Style (17th ed.) CitationKreye, Jakob, et al. Preclinical Safety and Efficacy of a Therapeutic Antibody That Targets SARS-CoV-2 at the Sotrovimab Face but Is Escaped by Omicron. Elsevier, 2023.
MLA (9th ed.) CitationKreye, Jakob, et al. Preclinical Safety and Efficacy of a Therapeutic Antibody That Targets SARS-CoV-2 at the Sotrovimab Face but Is Escaped by Omicron. Elsevier, 2023.
Warning: These citations may not always be 100% accurate.